RNS Number : 8167H Renalytix AI PLC 07 December 2020     Renalytix AI plc (" RenalytixAI " or the " Company ")   Result of AGM   Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney

RNS Number : 3041H Renalytix AI PLC 02 December 2020   Renalytix AI plc (" RenalytixAI " or the " Company ")   Partnership with National Kidney Foundation   to improve management of Early Stage Kidney Disease   Program focused on improving disease management and outcomes beginning at the primary

RNS Number : 5461G Renalytix AI PLC 26 November 2020   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing

RNS Number : 5327G Renalytix AI PLC 25 November 2020   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension

RNS Number : 5304G Renalytix AI PLC 25 November 2020   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

RNS Number : 3896G Renalytix AI PLC 25 November 2020     Renalytix AI plc ("RenalytixAI" or the "Company")   RenalytixAI Reports Financial Results for First Quarter of Fiscal Year 2021   NEW YORK , November 25, 2020   - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial

RNS Number : 1993F Renalytix AI PLC 13 November 2020     Renalytix AI plc (" RenalytixAI " or the " Company ")   RenalytixAI to Participate in the Stifel 2020 Healthcare Conference   NEW YORK , November 13, 2020   - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled

RNS Number : 4449E Renalytix AI PLC 06 November 2020       Renalytix AI plc (" RenalytixAI " or the " Company ")   Change of adviser   NEW YORK , November 6, 2020    - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on

RNS Number : 9886D Renalytix AI PLC 02 November 2020       Renalytix AI plc (" RenalytixAI " or the " Company ")   Posting of Annual Report & Accounts and Notice of AGM   NEW YORK , November 2, 2020    - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro

RNS Number : 3088D Renalytix AI PLC 27 October 2020     Renalytix AI plc (" RenalytixAI " or the " Company ")   Full Year Report   NEW YORK , October 27, 2020   - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing